Therapist barriers to the dissemination of exposure therapy

Handbook of Treating Variants and Complications in Anxiety Disorders

Volumn , Issue , 2013, Pages 363-373

  Deacon, Brett J ^a   Farrell, Nicholas R ^a  

^a UNIVERSITY OF WYOMING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84886408144     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-6458-7_23     Document Type: Chapter

References (51)

1. Abramowitz, J. S. (1996). Variants of exposures and response prevention in the treatment of obsessivecompulsive disorder: A meta-analysis. Behavior Therapy, 27, 583-600.
2. Abramowitz, J. S., Deacon, B. J., & Whiteside, S. P. (2010). Exposure therapy for anxiety: Principles and practice. New York: Guilford Press.
3. Addis, M. E., Wade, W. A., & Hatgis, C. (1999). Barriers to dissemination of evidence-based practices: Addressing practitioners concerns about manual-based psychotherapies. Clinical Psychology: Science and Practice, 6, 430-441.
4. American Psychiatric Association. (2011). American Psychiatric Association practice guidelines. Retrieved January 31, 2011, from http://www.psychiatryonline.com/pracGuide/pracGuideHome.aspx
5. American Psychological Association. (2002). Ethical principles of psychologists and code of conduct. Available on the World Wide Web http://www.apa.org/ethics/
6. APA Task Force on Evidence-Based Practice. (2006). Evidence-based practice in psychology. American Psychologist, 61, 271-285.
7. Baker, T. B., McFall, R. M., & Shoham, V. (2009). Current status and future prospects of clinical psychology: Toward a scientifically principled approach to mental and behavioral health care. Psychological Science in the Public Interest, 9, 67-103.
8. Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000). Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. Journal of the American Medical Association, 283, 2529-2536.
9. Barlow, D. H., Levitt, J. T., & Bufka, L. F. (1999). The dissemination of empirically supported treatments: A view to the future. Behaviour Research and Therapy, 37, S147-S162.
10. Becker, C., Zayfert, C., & Anderson, E. (2004). A survey of psychologists' attitudes toward utilization of exposure therapy for PTSD. Behaviour Research and Therapy, 42, 277-292.
11. Berke, D. M., Rozell, C. A., Hogan, T. P., Norcross, J. C., & Karpiak, C. P. (2011). What clinical psychologists know about evidence-based practice: Familiarity with online resources and research methods. Journal of Clinical Psychology, 67, 329-339.
12. Böhm, K., Förstner, U., Külz, A., & Voderholzer, U. (2008). Versorgungsrealität der zwangsstörungen: Werden expositionsverfahren eingesetzt? Verhaltenstherapie, 18, 18-24.
13. Brown, A., Deacon, B. J., Abramowitz, J. S., & Whiteside, S. P. (2007). Parents' perceptions of pharmacological and cognitive-behavioral treatments for childhood anxiety disorders. Behaviour Research and Therapy, 45, 819-828.
14. Clark, D. M., Layard, R., Smithies, R., Richards, D. C., Suckling, R., & Wright, B. (2009). Improving access to psychological therapy: Initial evaluation of two UK demonstration sites. Behaviour Research and Therapy, 47, 910-920.
15. Deacon, B. J., & Abramowitz, J. S. (2004). Cognitive and behavioral treatment for anxiety disorders: A review of meta-analytic findings. Journal of Clinical Psychology, 60, 429-441.
16. Deacon, B. J., & Abramowitz, J. S. (2005). Patients' perceptions of pharmacological and cognitive-behavioral treatments for anxiety disorders. Behavior Therapy, 36, 139-145.
17. Foa, E., Hembree, E., & Rothbaum, B. (2007). Prolonged exposure therapy for PTSD: Emotional processing of traumatic experiences, therapist guide. New York, NY: Oxford University Press.
18. Foa, E. B., & Rothbaum, B. O. (1998). Treating the trauma of rape: Cognitive-behavioral therapy for PTSD. New York, NY: Guilford Press.
19. Franklin, M., Huppert, J., Garcia, A., Freeman, J., March, J., & Foa, E. (2004, November). Therapist effects in a randomized controlled trial for pediatric OCD. Poster session presented at the annual meeting of the Association for Advancement of Behavior Therapy, New Orleans, LA.
20. Freiheit, S. R., Vye, C., Swan, R., & Cady, M. (2004). Cognitive-behavioral therapy for anxiety: Is dissemination working? The Behavior Therapist, 27, 25-32.
21. Garb, H. N., & Boyle, P. A. (2003). Understanding why some clinicians use pseudoscientific methods: Findings from research on clinical judgment. In S. O. Lilienfeld, S. J. Lynn, & J. M. Lohr (Eds.), Science and pseudoscience in clinical psychology (pp. 17-38). New York: Guilford Press.
22. Goisman, R. M., Warshaw, M. G., & Keller, M. B. (1999). Psychosocial treatment prescriptions for generalized anxiety disorder, panic disorder, and social phobia, 1991-1996. The American Journal of Psychiatry, 156, 1819-1821.
23. Gray, M. J., Elhai, J. D., & Schmidt, L. O. (2007). Trauma professionals' attitudes toward and utilization of evidence-based practices. Behavior Modification, 31, 732-748.
24. Gunter, R. W., & Whittal, M. L. (2010). Dissemination of cognitive-behavioral treatments for anxiety disorders: Overcoming barriers and improving patient access. Clinical Psychology Review, 30, 194-202.
25. Harned, M. S., Dimeff, L. A., Woodcock, E. A., & Skutch, J. M. (2011). Overcoming barriers to disseminating exposure therapies for anxiety disorders: A pilot randomized controlled trial of training methods. Journal of Anxiety Disorders, 25, 155-163.
26. Heuzenroeder, L., Donnelly, M., Haby, M. M., Mihalopoulos, C., Rossell, R., Carter, R., et al. (2004). Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder. Australia and New Zealand Journal of Psychiatry, 38, 602-612.
27. Hipol, L. J., & Deacon, B. J. (in press). Dissemination of evidence-based practices for anxiety disorders in Wyoming: A survey of practicing psychotherapists. Behavior Modification.
28. Hunsley, J., & Di Giulio, G. (2002). Dodo bird, phoenix, or urban legend: The question of psychotherapy equivalence. The Scientific Review of Mental Health Practice, 1, 11-22.
29. Kozak, M. J., & Foa, E. B. (1997). Mastery of obsessivecompulsivedisorder: Acognitive-behavioralapproach. San Antonio, TX: Graywind Publications.
30. Litz, B. (2002, November). The use of PE: Clinical decision making. Paper presented at the 18th annual meeting of the International Society for Traumatic Stress Studies, Baltimore, MD.
31. McHugh, R. K., & Barlow, D. H. (2010). The dissemination and implementation of evidence-based psychological treatments. American Psychologist, 65, 73-84.
32. National Institute for Clinical Excellence. (2011). Clinical guidelines. Retrieved January 31, 2011, from http://guidance.nice.org.uk/CG.
33. Norton, G. R., Allen, G. E., & Hilton, J. (1983). The social validity of treatments for agoraphobia. Behaviour Research and Therapy, 21, 393-399.
34. Olatunji, B. O., Cisler, J., & Deacon, B. J. (2010). Efficacy of cognitive behavioral therapy for anxiety disorders: A review of meta-analytic findings. Psychiatric Clinics of North America, 33, 557-577.
35. Olatunji, B. O., Deacon, B. J., & Abramowitz, J. S. (2009). The cruelest cure? Ethical issues in the implementation of exposure-based treatments. Cognitive and Behavioral Practice, 16, 172-180.
36. Pediatric OCD Treatment Study (POTS) Team. (2004). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessivecompulsive disorder: The Pediatric OCD Treatment Study (POTS) randomized controlled trial. Journal of the American Medical Association, 292, 1969-1976.
37. Persons, J. B., & Silberschatz, G. (1998). Are results of randomized controlled trials useful to psychotherapists? Journal of Consulting and Clinical Psychology, 66, 126-135.
38. Rachman, S., Radomsky, A., & Shafran, R. (2008). Safety behaviors: A reconsideration. Behaviour Research and Therapy, 46, 163-173.
39. Rapee, R. M., Gaston, J. E., & Abbott, M. J. (2009). Testing the efficacy of theoretically derived improvements in the treatment of social phobia. Journal of Consulting and Clinical Psychology, 77, 317-327.
40. Richard, D. C. S., & Gloster, A. T. (2007). Exposure therapy has a public relations problem: A dearth of litigation amid a wealth of concern. In D. C. S. Richard & D. Lauterbach (Eds.), Comprehensive handbook of the exposure therapies (pp. 409-425). New York: Academic Press.
41. Rothbaum, B. O., & Schwartz, A. C. (2002). Exposure therapy for posttraumatic stress disorder. American Journal of Psychotherapy, 56, 59-75.
42. Schmidt, N. B., Woolaway-Bickel, K., Trakowski, J., Santiago, H., Storey, J., Koselka, M., et al. (2000). Dismantling cognitive-behavioral treatment for panic disorder: Questioning the utility of breathing retraining. Journal of Consulting and Clinical Psychology, 68, 417-424.
43. Slater, L. (2003, November 3). The cruelest cure. New York Times.
44. Stein, M. B., Sherbourne, C. D., Craske, M. G., Means-Christensen, A., Bystritsky, A., Katon, W., et al. (2004). Quality of care for primary care patients with anxiety disorders. The American Journal of Psychiatry, 161, 2230-2237.
45. Tavris, C. (2003). The widening scientist-practitioner gap: A view from the bridge. In S. O. Lilienfeld, S. J. Lynn, & J. M. Lohr (Eds.), Science and pseudoscience in clinical psychology (pp. ix-xviii). New York: Guilford Press.
46. Taylor, C. B., King, R., Margraf, J., Ehlers, A., Telch, M., Roth, W. T., et al. (1989). Use of medication and in vivo exposure in volunteers for panic disorder research. The American Journal of Psychiatry, 146, 1423-1426.
47. van Minnen, A., Hendriks, L., & Olff, M. (2010). When do trauma experts choose exposure therapy for PTSD patients? A controlled study of therapist and patient factors. Behaviour Research and Therapy, 48, 312-320.
48. Weissman, M. M., Verdeli, H., Gameroff, M. J., Bledsoe, S. E., Betts, K., Mufson, L., et al. (2006). National survey of psychotherapy training in psychiatry, psychology, and social work. Archives of General Psychiatry, 63, 925-934.
49. Wolfe, R. M., Sharp, L. K., & Wang, R. M. (2004). Family physicians' opinions and attitudes to three clinical practice guidelines. The Journal of the American Board of Family Practice, 17, 150-157.
50. Young, A. S., Klap, R., Sherbourne, C. D., & Wells, K. B. (2001). The quality of care for depressive and anxiety disorders in the United States. Archives of General Psychiatry, 58, 55-61.
51. Young, A. S., Klap, R., Shoai, R., & Wells, K. B. (2008). Persistent depression and anxiety in the United States. Psychiatric Services, 59, 1391-1398.